Bone morphogenetic proteins (BMPs) have been shown to play a key role in controlling ectodermal cell fates by inducing epidermis at the expense of neural tissue during gastrulation. Here, we present evidence that the Xenopus POU class V transcription factor XOct-25 regulates ectodermal cell fate decisions by inhibiting the competence of ectodermal cells to respond to BMP during Xenopus embryogenesis. When overexpressed in the ectoderm after the blastula stage, XOct-25 suppressed early BMP responses of ectodermal cells downstream of BMP receptor activation and promoted neural induction while suppressing epidermal differentiation. In contrast, inhibition of XOct-25 function in the prospective neuroectoderm resulted in expansion of epidermal ectoderm at the expense of neuroectoderm. The reduction of neural tissue by inhibition of XOct-25 function could be rescued by decreasing endogenous BMP signaling, suggesting that XOct-25 plays a role in the formation of neural tissue at least in part by inhibiting BMP-mediated epidermal induction (neural inhibition). This hypothesis is supported by the observation that ectodermal cells from XOct-25 morphants were more sensitive to BMP signaling than cells from controls in inducing both immediate early BMP target genes and epidermis at the expense of neural tissue, while cells overexpressing XOct-25 are less competent to respond to BMP-mediated induction. These results document an essential role for XOct-25 in commitment to neural or epidermal cell fates in the ectoderm and highlight the importance of a regulatory mechanism that limits competence to respond to BMP-mediated embryonic induction.
Introduction
During early development of multicellular organisms, embryonic cells must communicate with neighboring cells via extracellular signals to form an organized body. Several groups of polypeptide growth factors such as transforming growth factor-bs (TGF-bs) and fibroblast growth factors (FGFs) have been shown to function as the extracellular signals responsible for the induction and patterning of germ layers (ectoderm, mesoderm and endoderm) (Harland and Gerhart, 1997; Muñ oz-Sanjuán and Hemmati-Brivanlou, 2001; Whitman, 2001) . Despite recent progress in understanding the molecular mechanisms of embryonic induction as well as growth factor signal transduction, regulatory mechanisms governing the competence of the responding tissue to extracellular signals during embryogenesis are not well understood.
Bone morphogenetic proteins (BMPs) and the related ligands activin/nodal are members of the TGF-b family that play essential roles in the specification and subsequent patterning of the germ layers (Massagué and Chen, 2000; Muñ oz-Sanjuán and Hemmati-Brivanlou, 2001; Whitman, 2001; Kishigami and Mishina, 2005) . Binding of these ligands to their cognate type I and type II cell-surface receptors results in phosphorylation of the type I receptor by the type II receptor. The activated type I receptor then transduces the signal via Smads into the nucleus where it regulates transcription. The specificity of signaling is primarily determined by type I receptors. BMPs and activin/ nodal have been shown to signal through different types of type I receptors: BMPs utilize ALK2 (ActRIA), ALK3 (BMPRIA) and ALK6 (BMPRIB), whereas activin/nodal uses ALK4 (ActRIB) and ALK7 instead (Shi and Massagué, 2003; Kishigami and Mishina, 2005) . In the ectoderm of early Xenopus embryos, BMP promotes epidermal differentiation by inducing expression of the Msx, Dlx, Vent and Id families of transcription factors that are responsible for inhibition of neural differentiation (Ladher et al., 1996; Onichtchouk et al., 1996; Ault et al., 1997; Suzuki et al., 1997a; Feledy et al., 1999; Yamamoto et al., 2000; Luo et al., 2001; Liu and Harland, 2003) . Several neural inducers possess an inhibitory activity for the BMP pathway and the secreted neural inducers Noggin and Chordin interfere with binding of BMP ligands to their receptors (Piccolo et al., 1996; Zimmerman et al., 1996; Harland and Gerhart, 1997; Chang and Hemmati-Brivanlou, 1998; De Robertis and Kuroda, 2004) . Although neural induction requires inhibition of BMP signaling, it is proposed that in the normal embryo, inhibition of the BMP pathway is not itself sufficient to complete this process (Stern, 2005) . This requires other cell intrinsic and/or extrinsic factors that potentiate the ability of cells to commit to a neural fate (Streit et al., 2000; Wilson et al., 2000 Wilson et al., , 2001 Sheng et al., 2003; Linker and Stern, 2004; Delaune et al., 2005) . Cell intrinsic factors are particularly important for the regulation of ectodermal competence to BMP signals, as these factors are expected to be directly involved in BMPinduced gene expression in the responding cells.
It has been shown that the competence of ectodermal cells to respond to BMP changes drastically during gastrulation. In chick embryos, BMP can induce presumptive neuroectoderm isolated from the early gastrula stage (which would otherwise become neural tissue) to form epidermal ectoderm. When the same treatment is carried out using presumptive neuroectoderm from the late gastrula stage, however, the ectoderm no longer responds to BMP and does form neural tissue (Wilson et al., 2000) . Thus, ectodermal competence to BMP-mediated epidermal induction is lost during gastrulation. Similarly, presumptive neuroectoderm of early, but not late, newt gastrulastage embryos can change its developmental fate to form epidermis when transplanted into epidermis-forming regions (Spemann, 1938; Saxén and Toivonenl, 1962) . This suggests that before the late gastrula stage, the ectoderm can respond to epidermis-inducing signals (presumably BMPs) emanating from the epidermal ectoderm cells. The Xenopus embryo is a good model system to address BMP-mediated embryonic induction processes because functions of the genes of interest can be spatiotemporally modified and a variety of embryological manipulations is available. Although several genes have been proposed to act as regulators of ectodermal competence to respond to BMP in Xenopus (Hartley et al., 2001; Bell et al., 2003; Takebayashi-Suzuki et al., 2003; Gestri et al., 2005) , the precise mechanisms of such regulatory pathways during embryogenesis remain to be elucidated.
POU class V proteins belong to a large gene family of POU-domain-containing transcription factors that are involved in the regulation of many differentiation processes (Rosenfeld, 1991; Ryan and Rosenfeld, 1997) . Mouse Oct-3/4 (mOct-3/4) is the most studied member of this subclass and has been shown to play a critical role in maintaining the inner cell mass, embryonic stem cells and germ line (Nichols et al., 1998; Niwa et al., 2000; Kehler et al., 2004; Niwa et al., 2005) . In Xenopus, three POU class V genes (XOct-25, XOct-60, XOct-91) have been identified, and their patterns of expression have been shown to be differentially regulated during early embryogenesis (Frank and Harland, 1992; Hinkley et al., 1992; Whitfield et al., 1993; Cao et al., 2004; Morrison and Brickman, 2006) . XOct-91 inhibits mesoderm induction by FGF and activin (Henig et al., 1998) . Recently, it has been shown that all three POU class V genes play a role in the formation of endomesodermal and ectodermal tissues by modulating the effects of activin, FGF, VegT and b-catenin (Cao et al., 2006; Morrison and Brickman, 2006; Snir et al., 2006; Cao et al., 2007) , or by acting downstream of the Notch pathway (Ito et al., 2007) . During zebrafish embryogenesis, the POU class V protein, Pou2/Spg, is implicated in gastrulation (Takeda et al., 1994) and, recently, has also been shown to control endoderm formation (Reim et al., 2004) and dorsoventral patterning of the mesoderm (Reim and Brand, 2006) . Pou2/Spg is also involved in the midbrain-hindbrain patterning during neurula stages (Belting et al., 2001; Burgess et al., 2002; Reim and Brand, 2002) . Despite sequence similarities among the vertebrate POU class V proteins, the degree of functional conservation of these proteins varies significantly Cao et al., 2006; Morrison and Brickman, 2006) , and thus each member of this protein family may play overlapping but distinct roles during embryogenesis.
In the present report, we screened for inhibitors of ectodermal competence to respond to BMP-mediated embryonic induction by seeking genes that suppressed constitutively activated BMP receptor-induced gene expression, on the assumption that the competence of responding cells is mainly regulated intracellularly after receptor activation. We identified a POU class V transcription factor, XOct-25, as an inhibitor of early BMP-dependent transcription. While increasing evidence suggested that XOct-25 has an essential role in germ layer formation, its function in ectoderm development, particularly in cell commitment to either neural or epidermal fates directed by BMP signaling, remained elusive. This is partly due to the fact that when XOct-25 function is manipulated early and widely in all three germ layers, a profound effect on both endomesodermal induction and gastrulation is observed prior to neural and epidermal commitment (Cao et al., 2006; Morrison and Brickman, 2006; Snir et al., 2006; Ito et al., 2007) . In order to circumvent this problem and precisely address the function of XOct-25 in the ectoderm, we spatiotemporally manipulated the activity of XOct-25 in the ectoderm using an inducible XOct-25 construct, local injection of RNAs and/or antisense oligonucleotides, and isolation of ectodermal explants. We found that activation of XOct-25 function in ectodermal explants from the blastula stage onward suppressed BMP-dependent transcription at the gastrula stage and promoted neural induction at the neurula stage. Consistent with its role in inhibition of the BMP pathway, we found that overexpression of XOct-25 in the ectoderm promoted commitment to a neural fate and inhibited the formation of epidermis without affecting mesodermal development. In addition, a loss-of-function analysis demonstrated that XOct-25 was involved in the choice between epidermal and neural fates in the ectoderm. Furthermore, using ectodermal cells isolated at the blastula stage, we found that XOct-25 was required for the inhibition of ectodermal competence to BMP signaling. We also showed that XOct-25 functions as a transcriptional activator to inhibit BMP-dependent transcription, suggesting a mechanism by which XOct-25 suppresses BMP responses via transcriptional activation of its downstream target genes.
Results

Identification of Xenopus Oct-25 as an inhibitor of BMP signaling
Previous work has shown that BMPs are prime candidates for epidermis-inducing factors acting during early vertebrate development (Muñ oz-Sanjuán and HemmatiBrivanlou, 2001) , and that by the late gastrula stage, the presumptive neuroectoderm loses its ability to differentiate into epidermis in response to BMPs or epidermis-inducing signals present in the presumptive epidermal ectoderm (Spemann, 1938; Saxén and Toivonenl, 1962; Wilson et al., 2000) . In an attempt to identify genes responsible for the loss of responsiveness to BMP during gastrulation, we sought those that suppressed BMP signaling after receptor activation by using an expression cloning strategy. Synthetic mRNAs from fractions of a gastrula stage library were injected together with a constitutively activated BMP receptor (CA-ALK2) mRNA (Suzuki et al., 1997b; Macías-Silva et al., 1998) into the animal blastomeres of 4-cell stage embryos and ectodermal explants were subsequently isolated at the blastula stage. Positive fractions that showed inhibitory activity against CA-ALK2-mediated ventral mesoderm induction were selected by quantifying the expression levels of the ventral marker gene a-globin in the ectodermal explants (see Section 4). As shown in Table 1 , screening 27 fractions, each consisting of approximately 100 independent clones, identified five which suppressed ectopically activated BMP signaling in the ectodermal explants. We then identified the genes responsible for the suppressive activity of two of these positive fractions. One was Xenopus Sox3 (Penzel et al., 1997; Genbank BC072222) , a member of the Sox gene family of highmobility-group (HMG) domain-containing transcription factors expressed in the neural plate. We did not study Sox3 further because the role of subgroup B1 Sox genes (Sox1-3) in neural development is already well-characterized (Mizuseki et al., 1998; Kishi et al., 2000; Bylund et al., 2003; Graham et al., 2003) . The other gene was identified as XOct-25, a Xenopus POU family transcription factor (Hinkley et al., 1992) . As shown in Fig. 1A , XOct-25 inhibited the expression of the a-globin gene induced by overexpression of CA-ALK2 in ectodermal explants.
We next asked whether XOct-25 affected the immediate early response to BMP signaling by analyzing the expression of BMP target genes at early gastrula stage (Fig. 1C) . XOct-25 and related genes have been shown to be involved in endomesoderm formation, which precedes neural and epidermal development of the ectoderm (Henig et al., 1998; Cao et al., 2006; Morrison and Brickman, 2006; Ito et al., 2007) . We therefore used a hormone-inducible XOct-25 (GR-XOct-25) (Fig. 6A ) to avoid any effect of its precocious overexpression before the blastula stage. The use of the inducible construct also allows activation of the function of XOct-25 at the time when BMP signaling induces immediate early target gene expression. Moreover, when combined with the ectodermal explant assay, the function of XOct-25 can be activated exclusively in the ectoderm after separation from the endomesoderm. We found that on dexamethasone (DEX) treatment, GRXOct-25 behaved similarly to the wild-type in the suppression of BMP signal-dependent a-globin gene expression (Fig. 1B) . Interestingly, as shown in Fig. 1C , XOct-25 efficiently suppressed CA-ALK2-induced expression of Msx1, Msx2, Dlx3, Dlx5 and Id2, but not of Vent2 or Id3 (lanes 7-9), suggesting that XOct-25 negatively regulates many, but not all, BMP response genes. A similar effect of XOct-25 on the basal expression of BMP response genes was also observed in the absence of CA-ALK2 (lanes 3-5). The negative effect of XOct-25 on BMP-dependent transcription was in sharp contrast to that of the extracellular BMP antagonist Noggin, which acts upstream of BMP receptor activation (Holley et al., 1996; Zimmerman et al., 1996) . Noggin could not suppress the expression of the BMP response genes in the presence of CA-ALK2 (lane 10). The finding that, unlike Noggin, XOct-25 suppressed It has been shown previously that XOct-25 is expressed uniformly in the animal half until the early gastrula stage and that its expression begins to be localized in neural tissues after the mid-gastrula stage (Hinkley et al., 1992; Cao et al., 2004; Morrison and Brickman, 2006; Cao et al., 2007) . We confirmed this observation by wholemount in situ hybridization (data not shown) and further discerned that XOct-25 expression was localized in the ventrolateral region of the neural plate by a comparison with the expression patterns of the dorsal neural marker Pax3 (Fig. 1D ) and the notochord and floor plate marker Kielin (Fig. 1E) . Although the role of XOct-25 in neural development, in addition to its role in endomesodermal development, was briefly explored by Cao et al. (2006) , its function in determining commitment to either neural or epidermal cell fate has not been analyzed. Therefore, in the following sections, we addressed this issue in relation to BMP signaling, using gain-and loss-of-function analyses of XOct-25 in the ectoderm of early Xenopus embryos.
To determine precisely the role of XOct-25 in neural and epidermal development, we injected mRNA encoding the inducible GR-XOct-25 together with b-galactosidase mRNA as a lineage tracer into one or two animal blastomeres of 8-or 16-cell stage embryo, and then activated the GR-XOct-25 after the blastula stage by treating the injected embryos with DEX (Fig. 2) . When GR-XOct-25 mRNA was injected into one dorsal animal blastomere (which mainly contributes to future neuroectoderm) of 8-cell stage embryo, expression of the neural plate markers Sox2 (82%, n = 51; Fig. 2B ) and Sox3 (77%, n = 35; data not shown) was expanded at the expense of the epidermal marker epidermal keratin (89%, n = 18; Fig. 2F ). Suppression of the epidermal marker Dlx3 was also evident (96%, n = 22; Fig. 2D ), especially when GR-XOct-25 mRNA was injected unilaterally into both dorsal and ventral animal blastomeres to encompass both future neural and epidermal regions of the ectoderm. Staining with the differentiated neuron marker N-tubulin and the proneuronal marker Xngnr-1 showed that XOct-25 slightly reduced Fig. 2 . XOct-25 promotes commitment to neural fate at the expense of epidermal fate. The phenotypes of neurula stage embryos coinjected with GR-XOct-25 mRNA (500 pg) together with b-galactosidase (b-gal) mRNA into either one of the dorsal animal blastomeres at the 8-cell stage (A, B, E, F and I-P) or one of the ventral animal blastomeres at the 16-cell stage (G and H). In C and D, mRNA was injected unilaterally into both dorsal and ventral animal blastomeres of 8-cell stage embryos in order to determine the effect on the epidermal region. Except for controls, injected embryos were treated with DEX from the blastula stage to activate GR-XOct-25 (Oct). The overexpression of GR-XOct-25 expanded the neural plate marker Sox2 at the expense of the epidermal markers epidermal keratin and Dlx3 (compare B with D and F). In the neuroectoderm, GR-XOct-25 moderately suppressed the expression of the neuronal markers N-tubulin and Xngnr-1 (J and L). There was no effect on the expression of the mesodermal markers chordin and MyoD by XOct-25 overexpression (N and P). The expression of marker genes is shown in purple. b-gal was stained in red and the injected side of the embryo is indicated by brackets. A-F and M: frontal view; N: dorso-frontal view; G and H: ventral view; I-L, O and P: dorsal view.
both N-tubulin (22%, n = 32; Fig. 2J ) and Xngnr-1 expression (25%, n = 24; Fig. 2L ). This suggests that XOct-25 might promote formation and/or maintenance of Sox2-positive neural progenitors or have a role in an initial transient process of neural induction (see Section 3). Expression of neither the axial mesoderm marker chordin (n = 13; Fig. 2N ) nor the somitic mesoderm marker MyoD (n = 14; Fig. 2P ) was affected by XOct-25 activation, indicating that the effect of XOct-25 on ectoderm does not result from a change in mesoderm differentiation. We observed that the expansion of the neural plate by XOct-25 was always contiguous to the neural plate and never found in ectopic locations at any distance from it (Fig. 2B ). This observation raises the possibility that XOct-25 may require local signals from the neural plate to direct epidermal ectoderm to differentiate into neuroectoderm. In order to test this possibility, we injected GRXOct-25 mRNA into one animal ventral blastomere of the 16-cell stage embryo; this blastomere contributes to epidermal cells at a distance from the neural plate. We found that XOct-25-positive cells (labeled with b-galactosidase) suppressed epidermal keratin expression (100%, n = 21; Fig. 2H ) without significantly inducing the neural plate marker Sox2 (n = 7, data not shown). This result suggests that while BMP signal inhibition by XOct-25 is capable of inhibiting epidermal differentiation, it is not sufficient to induce neural tissue, which may require additional signals from the neural plate. This conclusion is also in agreement with a recent proposal that in the normal embryo, inhibition of BMP signaling is necessary but not sufficient for neural induction (Stern, 2005) .
We next tested whether XOct-25 activation after the blastula stage in isolated ectodermal explants affects their commitment to a neural fate (Fig. 3) . It has been shown that inhibition of BMP signaling in the isolated ectoderm leads to neural induction; thus, this assay is useful to study the temporal and direct effects of XOct-25 activation on neural induction in isolation from the endomesoderm. When GR-XOct-25 was activated by DEX treatment immediately after isolation of the explant at the blastula stage (St. 8.5), XOct-25 weakly induced the neural marker NCAM (lane 7). Interestingly, together with small amounts of a dominant negative BMP receptor (DBMPR) mRNA, XOct-25 synergistically promoted commitment to a neural fate and inhibited epidermal development (lanes 8-10). In contrast, the neural-promoting effect of XOct-25 was not observed when activation was induced at the late gastrula stage (St. 12) (lanes 11-14) . While XOct-25 may possibly promote neural formation by increasing and/or maintaining the number of neural cells after neural induction, its temporal ability to promote neural fate before late gastrulation suggests that it plays an important role in the induction phase of neural development. Moreover, the neural promoting effect of XOct-25 activation in ectodermal explants separated from the endomesoderm also supports a direct involvement of XOct-25 in the induction of neural tissue and suppression of epidermis in the ectoderm.
We next examined if inhibition of XOct-25 function affects ectodermal differentiation using antisense morpholino oligonucleotides (MO) (Fig. 4) . We confirmed that an MO directed aginst the translation initiation site of XOct-25 mRNA (Oct MO), but not a 6-mismatch control MO, interfered with translation of XOct-25 mRNA in vitro (data not shown). In order to examine the effects of inhibition of XOct-25 on the neuroectoderm, we delivered Oct MO into the future neuroectoderm by injecting it into one animal dorsal blastomere of 8-cell stage embryos. Injection of a moderate amount of Oct MO (4.3-5.6 ng/embryo), but not control MO, resulted in a reduced expression of Sox2 (52%, n = 66; Fig. 4B ). Inhibition of XOct-25 function also caused the expression of the epidermal marker genes, epidermal keratin (79%, n = 52; Fig. 4H and I) and Dlx3 (57%, n = 30; Fig. 4K and L) to extend into neural plate territory. There was no significant effect on the expression Fig. 3 . Effect of temporal XOct-25 overexpression on neural induction. GR-XOct-25 mRNA (500 pg) was injected alone or together with increasing doses of DBMPR mRNA (30, 90 and 270 pg) into four animal blastomeres of 8-cell stage embryos. The ectodermal explants isolated at the blastula stage were cultured in the absence (lanes 3-6) or presence of DEX from either blastula (St. 8.5; lanes 7-10) or late-gastrula stage onward (St. 12; lanes 11-14) to activate XOct-25 function. The expression of marker genes was determined at the neurula stage.
of the mesodermal marker genes chordin (n = 13; Fig. 4N ) and MyoD (n = 16; Fig. 4P) . Furthermore, as shown in Fig. 4C , the reduction of Sox2 expression caused by a moderate amount of Oct MO was partially rescued by coinjection of a dominant negative BMP receptor (DBMPR) mRNA (the percentage of embryos with reduced Sox2 expression decreased to 17% (n = 76)). This observation indicates that XOct-25 is involved in the ectodermal cell fate decision-making processes, at least in part, by inhibition of the BMP signaling pathway.
When a relatively large amount of Oct MO (8.6 ng/ embryo) was used with the aim of raising the penetrance and degree of the Oct MO phenotype, the injected embryos displayed a more pronounced reduction of Sox2 expression, with an improved penetrance (77%, n = 52; Fig. 4E ). The pronounced reduction of Sox2 was almost completely rescued by coinjection of a modified version of GR-XOct-25 (GR-mutXOct-25) mRNA that has mutations preventing translational inhibition by Oct MO: only 2% (n = 64) of embryos showed reduced Sox2 expression (Fig. 4F) . However, DBMPR mRNA was not as effective as GR-mutXOct-25 RNA at rescuing the defect: 34% (n = 67) of DBMPR mRNA-injected embryos still showed reduced Sox2 expression (data not shown). In addition, we also observed that ectopic expression of the epidermal keratin gene in the neuroectoderm was poorly induced by injection of high-dose Oct MO: 16% of injected embryos (n = 92) showed ectopic keratin expression (data not shown) compared to 79% (n = 52; Fig. 4H and I ) of embryos injected with a moderate amount of Oct MO. Similarly, when XOct-25 function was knocked down by Oct MO in the ectodermal explants, neuralization induced by DBMPR mRNA injection was partially suppressed, while the reduction of neural tissue was associated with only a small reciprocal increase in the expression of epidermal keratin ( Fig. S1 ; lanes 9 and 10). One possible explanation for these results is that while XOct-25 plays an essential role in the choice between neural and epidermal cell fates, a certain level of XOct-25 function might be, in part, involved in maintaining the proper development of the ectoderm. Although the characteristics of the cell types that display the severely reduced Sox2 expression are uncertain, deregulation of gene expression could be a com- b mon consequence of the loss of Sox2 function that affects neuroectoderm development (Kishi et al., 2000; Bylund et al., 2003; Graham et al., 2003) .
In summary, the results of the experiments described above suggest that XOct-25 promotes commitment to neural fate and inhibits epidermal differentiation during the early stages of ectodermal development, and that these effects are mediated, at least in part, by inhibition of early BMP responses in the ectoderm.
XOct-25 inhibits ectodermal competence to BMP
In order to explore the role of XOct-25 in the commitment to a neural or epidermal fate directed by the BMP signaling pathway, we first tested whether overexpression of XOct-25 regulates responsiveness to BMP signaling ( Fig. 5A and B) . We utilized dissociated ectodermal cells to eliminate background levels of expression of BMP response genes that are dependent on endogenous BMP signaling (Ladher et al., 1996; Suzuki et al., 1997a) . This experimental system allows us to measure precisely the responses of ectodermal cells to exogenous BMP signaling. The dissociation of ectodermal cells for about 3 h followed by reaggregation also results in neural induction at the expense of epidermis when the aggregates are cultured to the neurula stage, and exogenous BMP signaling can induce epidermis and inhibit neural induction in this system (Wilson and Hemmati-Brivanlou, 1995) . We examined the expression of BMP response genes in dissociated ectodermal cells injected with GR-XOct-25 and increasing doses of CA-ALK2 mRNAs. As shown in Fig. 5A , activation of GR-XOct-25 during the gastrula stages suppressed the expression of several BMP response genes (lanes 10-15). In agreement with this result, overexpression of XOct-25 inhibited epidermal fate and promoted neural fate when dissociated ectodermal cells were reaggregated and cultured until they reached the neurula stages (Fig. 5B, lanes  10-15) . We next investigated whether XOct-25 is required for the regulation of competence of the ectoderm to respond to BMP signaling ( Fig. 5C and D) . We examined the expression of BMP response genes in dissociated ectodermal cells injected with Oct MO and an increasing dose of CA-ALK2 mRNA. As shown in Fig. 5C , RT-PCR analysis of the expression of the early BMP response genes at the gastrula stage showed that the dissociated ectodermal cells from Oct MO-injected embryos responded better than controls (6 mis MO) to increasing doses of CA-ALK2-mediated BMP signaling (compare lanes 5-10 and lanes 11-16). A similar conclusion was arrived at by examining the terminal differentiation markers epidermal keratin and NCAM at the neurula stage (Fig. 5D) . The gain-and loss-of-function analyses of XOct-25 using dissociated ectodermal cells clearly indicate that XOct-25 plays a pivotal role in ectodermal cell fate decisions by negatively regulating the competence of ectodermal cells to respond to BMP-mediated embryonic induction.
XOct-25 functions as a transcriptional activator to inhibit BMP signaling
It is known that depending on cellular context, transcription factors of the POU family act as either transcriptional activators or repressors (Rosenfeld, 1991; Ryan and Rosenfeld, 1997) . We therefore assessed the mode of action of XOct-25 in the suppression of BMP-dependent transcription. First, we sought to determine the importance of the N-and C-terminal portions that flank the POUdomain of the XOct-25 protein in the regulation of BMP signaling, because both portions are required for mouse Oct-3/4 to maintain the undifferentiated state of embryonic stem cells (Niwa et al., 2002) . When N-terminal or C-terminal deletion mutants of XOct-25 (Fig. 6A) were coexpressed with CA-ALK2, we found that the former failed to inhibit BMP signal-induced a-globin gene expression (Fig. 6B) , indicating that the N-terminal portion is essential for XOct-25 suppression of BMP signaling. Next, we replaced the N-terminal portion with either the repressor The N-terminus of XOct-25 is important for the inhibition of BMP signaling. CA-ALK2 mRNA (150 pg) was injected alone or together with either DN-or DC-XOct-25 mRNA (100 pg) into the animal pole of 4-cell stage embryos. Ectodermal explants isolated at the blastula stage were cultured until the tailbud stage and analyzed by RT-PCR for expression of the a-globin gene. (C) XOct-25 functions as a transcriptional activator. CA-ALK2 mRNA (150 pg) was injected alone or together with either wild-type, En-or VP-XOct-25 mRNA (200 pg for lanes 5, 7 and 9; 400 pg for lanes 6, 8 and 10) into the animal pole of 4-cell stage embryos and the expression of the a-globin gene was analyzed as described in B. (D) A model of XOct-25-mediated inhibition of BMP signaling and the regulation of ectodermal cell fate decision. XOct-25 inhibits ectodermal competence to BMP-mediated epidermal induction (neural inhibition) by repressing expression of a subset of BMP response genes. Because XOct-25 functions as a transcription activator to inhibit BMP responses, it is possible that XOct-25 acts through its downstream target genes (X). There is also a possibility that XOct-25 suppresses BMP-dependent gene expression without the need for X (see Section 3). As a result, XOct-25 promotes commitment to neural fate at the expense of epidermal differentiation in the ectoderm. domain of Drosophila engrailed or the activator domain of herpes simplex virus VP16 and tested the activity of these fusion proteins in the regulation of BMP signaling. A reporter gene assay established for mouse Oct-3/4 confirmed that VP-XOct-25 and En-XOct-25 function as a transcriptional activator and a repressor, respectively, (Fig. S2) . As shown in Fig. 6C , VP-XOct-25, but not EnXOct-25, inhibited a-globin gene expression induced by CA-ALK2, mimicking the function of wild-type XOct-25. These results suggest that XOct-25 functions as a transcriptional activator, and raises the possibility that XOct-25 may require the function of its downstream target genes to inhibit BMP signaling in Xenopus embryos.
Discussion
In this study, we determined the role of XOct-25 in ectoderm development and showed that it promoted commitment to a neural fate and inhibited epidermal differentiation by negatively regulating the competence of the ectoderm to respond to BMP-mediated embryonic induction.
For gain-of-function analysis, we utilized an inducible XOct-25 construct to analyze temporal effects on neural and epidermal development. A combination of restricted delivery of the mRNA, as well as an antisense oligonucleotide against XOct-25, into blastomeres that contribute to the ectoderm enabled us to investigate the local effect of modifying XOct-25 activity on ectodermal development. In particular, activation of XOct-25 function in the isolated ectoderm demonstrated a specific role of XOct-25 in the ectoderm, separate from any influence of the endomesoderm. Furthermore, dissociated ectodermal cell assays, in conjunction with gain-and loss-of-function experiments with XOct-25, provided an opportunity to precisely analyze the role of XOct-25 in the regulation of BMP responses of ectodermal cells during neural and epidermal cell fate decision-making. These approaches allowed us to identify unique functions of XOct-25 in the ectoderm during early Xenopus development.
XOct-25 plays multiple roles during early Xenopus development
XOct-25 is expressed uniformly in the animal half of embryos by the early gastrula stage and its localized zygotic expression in the future neural plate becomes apparent from the mid-gastrula stage (Hinkley et al., 1992; Cao et al., 2004; Morrison and Brickman, 2006; Cao et al., 2007) . This biphasic expression pattern suggests that XOct-25 may have multiple roles during early Xenopus development. Recently, two independent reports have documented that XOct-25 negatively regulates activin-mediated endomesoderm specification and that dysregulation of XOct-25 function affects not only early endomesoderm induction, but also later developmental processes including neural development (Cao et al., 2006; Morrison and Brickman, 2006) . In these reports, however, prior to neural development, a profound effect on the endomesoderm formation was observed, probably due to early and widespread effects of manipulating XOct-25 function. Thus, it is difficult to rule out the possibility that the observed neural defects could be the result of endomesodermal defects. In contrast to these previous reports, we focused on the role of XOct-25 in the ectoderm by locally injecting an inducible XOct-25 into the animal blastomere of 8-cell stage embryos, and found that upon activation after the blastula stage, XOct-25 promoted commitment to a neural fate and inhibited epidermal differentiation without affecting mesoderm formation (Fig. 2) . In addition, activation of XOct-25 function in ectodermal explants after separation from the endomesoderm suppressed BMP target gene expression (Fig. 1C) and promoted neural induction (Fig. 3) . Furthermore, the role of XOct-25 in ectodermal development was confirmed by functional knockdown of XOct-25 in the neuroectoderm by injecting a specific morpholino oligonucleotide into one dorsal animal blastomere (which preferentially contributes to the neuroectoderm) of 8-cell stage embryos (Fig. 4) . By extending these findings further, our gain-and loss-of function analyses of XOct-25 in dissociated ectodermal cells demonstrated that XOct-25 inhibits the ability of the ectoderm to respond to BMP signaling (Fig. 5) . Therefore, the results of our analyses presented here, together with those published previously, suggest that XOct-25 has multiple and distinct roles in specification not only of the endomesoderm but also of the ectoderm. Moreover, XOct-25 plays an essential role in the choice between neural and epidermal cell fates directed by BMP signaling.
While our analysis clearly demonstrated the role of XOct-25 in the ectoderm, functional analyses of Xenopus POU class V proteins carried out by others have provided complex and somewhat contradictory results on the transcriptional regulation of marker genes by the POU proteins. Morrison and Brickman (2006) reported that knockdown of all the three POU proteins in the whole embryo from the 2-cell stage onward results in the downregulation of the ventrally expressed BMP4 and Xom (Vent2) genes and of the pan-mesodermal marker Xbra, and expansion of expression of the endodermal markers, Mixer and XSox17. Similarly, Ito et al. (2007) showed that inhibition of XOct-25 in the marginal zone by a dominant negative mutant leads to loss of Xbra expression. In contrast to these observations, Cao et al. (2006) showed that knockdown of two of the POU class V proteins (XOct-25 and XOct-60) from the 4-cell stage onward, causes expansion of Xbra expression domain into the ectoderm along with expansion of the endoderm as detected by the endodermal marker gene Xsox17. Likewise, Snir et al. (2006) reported that knockdown of XOct-91 alone can cause expansion of Xbra expression domain into the ectoderm. Although there is no unequivocal explanation for the complexity of Xbra expression, it is possible that the POU class V proteins are initially essential for establishing territories of germ layers, and spatiotemporal differences in the degree of knockdown of these proteins in the whole embryo may result in phenotypic variation in the germ layer formation by blastula stages. Under this scenario, in addition to effects on expression of the mesodermal layer specific gene Xbra, dysregulation of the POU class V proteins might affect indirectly and differentially expression of regional marker genes of the early gastrula, such as BMP4 and Vent2, not only through changes in the territories of each germ layer but also by secreted factors emanating from affected neighboring tissues. Although there are other possible explanations, this possibility might account for the observation that activation of XOct-25 in the isolated ectoderm after the blastula stage did not result in a profound change in the expression of BMP4 or Vent2, but did suppress expression of a subset of BMP response genes (Fig. 1C) . Further analyses will be required to elucidate the mechanisms of action of Xenopus POU class V proteins operating in each germ layer during early embryogenesis.
XOct-25 inhibits immediate early BMP responses in the ectoderm
In a detailed analysis of the expression of immediate early BMP target genes following XOct-25 activation, we found that XOct-25 inhibits the expression of only a subset of BMP target genes, namely Msx1, Msx2, Dlx3, Dlx5 and Id2, but not Vent2 or Id3 genes (Fig. 1C) . As most of these gene families have been shown to contain functional Smadbinding sites in their promoters (Hata et al., 2000; Henningfeld et al., 2000; Alvarez Martinez et al., 2002; Korchynskyi and ten Dijke, 2002; Park and Morasso, 2002; Hussein et al., 2003; Brugger et al., 2004; von Bubnoff et al., 2005; Binato et al., 2006) , the selective inhibitory effect of XOct-25 may involve cis-regulatory elements other than Smad sites. It has been reported that XOct-25 stimulates Vent2 gene expression by directly binding to its promoter (Cao et al., 2004) . Although the physiological significance of this regulation is obscure, the activation of Vent2 transcription by XOct-25 might partly explain the inability of XOct-25 to suppress Vent2 expression.
In the course of this investigation of the transcription function of XOct-25, we discovered that XOct-25 acts as a transcriptional activator which presumably requires its downstream target gene expression to inhibit BMP signaling ( Fig. 6C and D) . However, there remains a possibility that XOct-25 is directly involved in the inhibition of BMP responses, given the fact that POU class V proteins can repress gene expression by forming a complex with other transcription factors such as FoxD3, Cdx2 and VgT (Guo et al., 2002; Niwa et al., 2005; Cao et al., 2007) . Moreover, mouse Oct-3/4 (mOct-3/4) can repress transcription and occupy the promoter region of, developmentally regulated genes (Loh et al., 2006) . Since the indirect and direct modes of repression are not necessarily mutually exclusive, in future studies, it will be important to identify the downstream target genes of XOct-25 that are responsible for the suppression of BMP responses. A possible candidate gene downstream of XOct-25 might be Sox2, because the mouse Sox2 gene is a direct target of mOct-3/4 (Catena et al., 2004) and XOct-25 is capable of inducing Sox2 expression in Xenopus embryos (Fig. 2 ) and ectodermal explants (Cao et al., 2006 ; K.T.-S., data not shown). In addition, similar to XOct-25, Sox2 is also required for neural induction and is capable of promoting neural development (Mizuseki et al., 1998; Kishi et al., 2000) . While Sox2 is evidently involved in neural induction, it is possible that there are multiple genes acting downstream of XOct-25 during ectodermal development, as has been shown for mOct-3/4 in ES cells (Loh et al., 2006; Matoba et al., 2006) . Functional analysis of the XOct-25 downstream genes in neural and epidermal development as well as of cis-regulatory elements of BMP response genes will be necessary to further understand the mechanism of XOct-25-mediated inhibition of BMP signaling.
It is also important to ask whether the inhibitory effect of XOct-25 on BMP signaling is shared with other members of vertebrate POU class V proteins. It is particularly interesting to address the question of whether mammalian Oct-3/4 genes suppress BMP signaling. Both mOct-3/4 and BMP ligands play essential roles in the early cell fate decisions of embryonic and extraembryonic tissues (Nichols et al., 1998; Niwa et al., 2000; Ying et al., 2003; Qi et al., 2004; Kishigami and Mishina, 2005; Niwa et al., 2005) . In adults, these factors are also implicated in tumorigenesis (Gidekel et al., 2003; Waite and Eng, 2003; Hochedlinger et al., 2005) . Therefore, it is possible that mammalian Oct-3/4 might modulate BMP signaling during development and homeostasis. Similar to our observation on the overexpression of XOct-25 in the Xenopus ectoderm, it has been shown that induction of mOct-3/4 expression in mouse embryonic stem cells promotes neural development under LIF-deficient neural differentiation culture conditions (Shimozaki et al., 2003) . In addition, mOct-3/4 is expressed broadly in the embryonic ectoderm including the neural ectoderm at 7.5 dpc and in the posterior headfold as well as in the posterior neural plate by 8.5 dpc (Rosner et al., 1990; Perea-Gó mez et al., 1999) . Recently, Okuda et al. (2004) reported that mOct-3/4 is expressed in some of the dividing neural cells of the E14 mouse embryonic brain. Despite the above observations, however, the evidence for functional and genetic interactions between mOct-3/4 and BMP signal in the mouse is currently lacking. Moreover, it has been shown that XOct-25 only partially rescues the stem cell state when expressed in mOct-3/4 null ES cells, indicating that the functional conservation between XOct-25 and mOct-3/4 might be limited (Morrison and Brickman, 2006) . In a future study, it will be necessary to precisely address the issue of functional conservation among vertebrate POU class V proteins in the regulation of the BMP response during development.
In Xenopus, three POU class V genes are expressed and have been shown to have partly redundant functions in endomesoderm formation (Hinkley et al., 1992; Cao et al., 2006; Morrison and Brickman, 2006; Ito et al., 2007) . Similarly, we observed that knockdown of all three POU class V genes in the ectoderm by injecting XOct-25 MO (Oct MO) together with XOct-91-and XOct-60-specific MOs (Cao et al., 2006; Snir et al., 2006) exacerbated the neural defects caused by Oct MO alone (embryos with reduced Sox2 expression increased to 93% (n = 45) in the XOct-25/60/91 triple morphant compared to 44% (n = 48) in XOct-25 single morphants; Fig. S3 ) In addition, the reduction of Sox2 expression caused by XOct-25 MO is partially rescued by overexpression of XOct-91, which has been shown to be involved in neural development and the expression of which resembles that of XOct-25 (Frank and Harland, 1992; Morrison and Brickman, 2006; Snir et al., 2006) (embryos with reduced Sox2 expression decreased from 77% (n = 57) to 23% (n = 56); Fig. S4 ). Therefore, there must be functional redundancy among the three POU class V genes in the ectoderm as is the case for the endomesoderm. Although a careful examination of any such functional redundancy will be necessary in future due to the tetraploid nature of the Xenopus laevis genome, XOct-25 may play roles distinct from but overlapping with other POU genes in the regulation of ectodermal development.
XOct-25 is a negative regulator of ectodermal competence to respond to BMP
It has been shown that competence of the presumptive neuroectoderm to BMP-mediated embryonic induction or epidermis-inducing signals is lost during gastrulation (Spemann, 1938; Saxén and Toivonenl, 1962; Wilson et al., 2000) . Our gain-and loss-of-function analysis of XOct-25, the expression of which begins to be confined to the future neuroectoderm from the mid-gastrula stage, showed that XOct-25 played an important role in the inhibition of BMP responses in ectodermal cells during gastrula stages (Fig. 5) . This result raises the possibility that XOct-25 may be involved in the loss of competence of the presumptive neuroectoderm to respond to BMP in the normal embryo. This possibility could be tested by isolating the presumptive neuroectoderm from late gastrula embryos, inactivating XOct-25 function, and then evaluating the BMP response of the isolated ectoderm. Currently, however, because of the technical difficulty involved in temporal inactivation of XOct-25 function after the isolation of the presumptive neuroectoderm, the extent to which XOct-25 contributes to the loss of ectodermal competence to respond to BMP at the late gastrula stage remains unclear at the present time and will need to be addressed in future studies. It is important to note that the activation of XOct-25 from the blastula stage onward, but not at the late gastrula stage (St. 12), promoted neuralization of the ectoderm synergistically with inhibition of BMP signaling (Fig. 3) . This result suggests that XOct-25 is capable of regulating the responsiveness of the ectoderm to BMP by the late gastrula stage at which neural induction takes place. Therefore, it would be reasonable to assume that XOct-25 functions in the process of neural induction by regulating early responses to BMP signaling rather than by maintaining neural tissue already induced at the gastrula stage. In addition to the temporal ability of XOct-25 to promote neural induction, the synergistic action of XOct-25 with inhibition of BMP signaling suggests that XOct-25 may also function to permit acquisition of neural fate by inhibiting that of epidermal fate in response to BMP signaling. Thereby, XOct-25 might cooperates with neural inducers to induce neural tissue and to suppress epidermal differentiation.
We showed that overexpression of XOct-25 in the whole embryo expanded the neural plate marker Sox2 and slightly reduced expression of the differentiated neuron marker N-tubulin (Fig. 2B and J) . Cao et al. (2006) also demonstrated that in ectodermal explants, XOct-25 can activate Sox2 gene without inducing N-tubulin gene expression. Therefore, these findings suggest that XOct-25 might be involved in the formation and/or maintenance of undifferentiated neural progenitors. Similarly to the effects of XOct-25 overexpression, inhibition of BMP signaling by a Smad7 mutant causes expansion of Sox2 expression with reduced expression of N-tubulin (Wawersik et al., 2005) . A completion of neural induction and neuronal differentiation are promoted when BMP inhibition is combined with FGF (Reversade et al., 2005; Stern, 2005) . These suggest an alternative possibility that XOct-25 might play a role in the initial transient step of neural induction process in cooperation with BMP inhibition by suppressing BMP-mediated epidermis-inducing (neural inhibiting) signals. This alternative could explain why ectopic expression of XOct-25 in the ventral ectoderm at a distance from the neural plate only suppressed epidermal keratin expression and did not induce Sox2 expression (Fig. 2H) , similar to the observation made for the inhibition of BMP signaling (Linker and Stern, 2004; Delaune et al., 2005) .
There are a number of genes that inhibit BMP signaling in responding cells of developing embryos. The pseudotype BMP receptor BAMBI inhibits BMP signaling at the cell membrane level (Onichtchouk et al., 1999) . Inhibitory Smads (Smad6 and Smad7), Smad ubiquitin ligases (Smurf1 and Ectodermin), XMAN1 and Tob2 inhibit Smad-mediated intracellular BMP signaling (Casellas and Hemmati-Brivanlou, 1998; Hata et al., 1998; Zhu et al., 1999; Osada et al., 2003; Yoshida et al., 2003; Dupont et al., 2005) . In comparison with previously characterized suppressors of intracellular BMP signaling, the inhibitory action of XOct-25 has a unique characteristic: XOct-25 suppresses a subset of BMP target genes, without affecting the well-known BMP target gene Vent2 (Fig. 1C) . This unique action may partly explain the regulatory role of XOct-25 in the ectodermal competence to respond to BMP, rather than in the blockade of BMP signaling (Fig. 5) . It may also explain the relatively weak activity of XOct-25 in promoting commitment to neural fate both in the embryo (Fig. 2) and in isolated ectodermal explants ( Fig. 3 ; Cao et al., 2006) . In summary, XOct-25 may play a permissive rather than instructive role in ectodermal cell fate decisions by regulating responsiveness of these cells to BMP signaling. We propose that XOct-25 inhibits epidermal fate and promotes neural fate by desensitizing ectodermal cells to BMP-mediated epidermal induction (neural inhibition) by suppressing the expression of a subset of BMP target genes (Fig. 6D ).
Experimental procedures
Embryo manipulations
Preparation and injection of X. laevis embryos and the dissociation and reaggregation of ectodermal cells were carried out as previously described (Suzuki et al., 1997a) . Embryos were staged according to Nieuwkoop and Faber (Nieuwkoop and Faber, 1967) . Dexamethasone (DEX) treatments were performed as described previously (Suzuki and Hemmati-Brivanlou, 2000) except that 2 lM of DEX was used for culturing ectodermal cells. Antisense morpholino oligonucleotides (MO) were obtained from Gene Tools (Philomath, USA). The sequence of the MO against XOct-25 was Oct MO, 5 0 -AGG GCT GTT GGC TGT ACA TGG TGT C-3 0 , and that of the 6-mismatch control MO was 5 0 -AGG cCT GaT GGg TGa ACt TGG aGT C-3 0 . The sequences of the MOs for XOct-60 (Oct60MOa1 and Oct60MOb1) and XOct-91 (XLPOU91 MO) were obtained from the papers of Cao et al. (2006) and Snir et al. (2006) , respectively.
Expression cloning and RT-PCR analysis
The Xenopus gastrula expression library (Weinstein et al., 1998; Suzuki and Hemmati-Brivanlou, 2000) was divided into pools of 100 independent clones, and plasmids were prepared from each pool. Capped RNAs synthesized from the plasmids were injected in combination with a constitutively activated BMP type I receptor (CA-ALK2) mRNA in the animal pole of 4-cell embryos. Ectodermal explants isolated at the blastula stage were subjected to RT-PCR analysis at the tailbud stage for the a-globin gene expression. Positive pools which suppressed a-globin gene expression were subdivided, and the explant assays and sib selection were repeated until a single clone was isolated (Table 1) . Two positive clones were successfully isolated after screening 27 fractions (approximately 2700 independent clones) and their sequences were determined to be XOct-25 (Hinkley et al., 1992) and XSox3 (Penzel et al., 1997) . The full-length sequence of the XOct-25 cDNA was deposited with GenBank (Accession No. DQ825761). Primers used in the RT-PCR were described previously (Suzuki et al., 1997a,b,c; Suzuki and Hemmati-Brivanlou, 2000) . Other primer sequences were as follows: Msx2, 5 0 -CGC AAT GTC TTC TCC CAG GA-3 0 and 5 0 -ACC AGC TGG TGC CAT CTT CG-3 0 ; Dlx3, 5 0 -GAA GAT GGC CGT GTT GAC CG-3 0 and 5 0 -GGG TAG CCG TAG GAG CTG AT-3 0 ; Dlx5, 5 0 -GGA GAG TCG CCT CCA TCC GA-3 0 and 5 0 -GCG CCT TTC CAT AAG TGG CC-3 0 ; Id2, 5 0 -GTC TCC ATC ATC TCC CCC GA-3 0 and 5 0 -CGT CTG TGA ACT CTG AAG AG-3 0 ; Id3, 5 0 -TTG GCA ACA CAA GGG GAC AC-3 0 and 5 0 -TGG AAA TCG GGA GGG TTT AGT C-3 0 .
Lineage tracing and whole-mount in situ hybridization
Embryos were fixed for 30 min at RT in MEMFA, washed with PTW, and stained with 6-chloro-3-indolyl-b-D-galactoside (red-gal; Research Organics, Cleveland) for lineage labeling. Stained embryos were then refixed for 24 h in MEMFA and stored in ethanol at À20°C. Wholemount in situ hybridization was performed essentially as described previously (Takebayashi- Suzuki et al., 2003; Hollemann et al., 1996) .
For double color in situ hybridization, the fluorescein-labeled probe was stained with BCIP (light blue; Roche) and the other DIG-labeled probe was stained with BM purple (purple; Roche). Template plasmids for probe synthesis were as follows: pDH105-XOct-25, Pax3 (Espeseth et al., 1995) , Kielin (Matsui et al., 2000) , Sox2 (Mizuseki et al., 1998) , Sox3 (Penzel et al., 1997; unpublished) , epidermal keratin (Jonas et al., 1985) , Dlx3 (Papalopulu and Kintner, 1993) , chordin (Sasai et al., 1994) , N-tubulin (Chitnis et al., 1995) , Xngnr-1 (Ma et al., 1996) and MyoD (Hopwood et al., 1989) . Stained embryos were refixed in MEMFA and sectioned at 20 lm with a cryostat as described previously (Kurata et al., 2001 ).
Luciferase assay
A reporter gene for mouse Oct-3/4 (6Wtk) (Niwa et al., 2002) that has previously been shown to respond to Xenopus POU class V genes (Morrison and Brickman, 2006) was injected together with eitherVP-XOct-25 or En-XOct-25 mRNA (400 pg each) into four animal blastomeres of the 8-cell stage embryo. The injected embryos were lysed at the blastula stage and luciferase activity was measured using the dual-luciferase assay system (Promega) as described previously (Takebayashi-Suzuki et al., 2003) . pXeX-RL and tk-Luc were used as an internal control for the luciferase assay and a negative control for 6Wtk, respectively.
Plasmids
GR-XOct-25, GR-mutXOct-25, DN-XOct-25, DC-XOct-25, En-XOct-25 and VP-XOct-25 were made by a PCR-based strategy. The PCR fragments were digested with restriction enzymes and cloned into appropriate expression vectors: pDH105 (a gift from Dr. R. Harland), pDH105-GRHA (Takebayashi- Suzuki et al., 2003) , pCS2-ENG-N and pCS2-VP16-N, both of which were gifts from Dr. D. Kessler. The following primer combinations and restriction enzymes were used: GR-XOct-25, SP6 and OctGR (D) (5 0 -CCG CTC GAG GCC AAT GTG GCC CCC CAT GGC-3 0 ), digested with ClaI and XhoI; GR-mutXOct-25, mutOctGR (U) (5 0 -ACG TTC GAG AAC CTG AGG TAC CTA TCA GTC GTT GGG AAG GGT CGG AAG-3 0 ) and OctGR (D), digested with ClaI and XhoI; DN-XOct-25, OctDN (5 0 -CGG AAT TCA TGC AAT CCA GCG ACA ATG AGG-3 0 ) and pDH3 0 (5 0 -CTT ATC ATG TCT GGA TCT ACG-3 0 ), digested with EcoRI and NotI; DC-XOct-25, SP6 and OctDC (5 0 -GCT CTA GAC TAG CCG TCG TTC TCC TCA AC-3 0 ), digested with EcoRI and XbaI; En-XOct-25, OctEn (U) (5 0 -CCG CTC GAG TCA ATC CAG CGA CAA TGA GGA G-3 0 ) and pDH3 0 , digested with XhoI and XbaI; VP-XOct-25, OctVP (U) (5 0 -CCG CTC GAG CAA TCC AGC GAC AAT GAG GAG-3 0 ) and pDH3', digested with XhoI and XbaI XOct-91 cDNA obtained from the NIBB XDB catalogue (http://Xenopus.nibb.ac.jp) was subcloned into pDH105. Other plasmids used for mRNA synthesis were pSP64TBX-CA-ALK2 (Suzuki et al., 1997b) and pSP6nucbgal (Smith and Harland, 1991) . In vitro translation of synthetic mRNA was carried out using the Speed Read lysate kit (Novagen) and SDS-PAGE was performed using standard methods. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan, grants from the Asahi Glass Foundation, Uehara Memorial Foundation, the Naito Foundation, Saneyoshi Scholarship Foundation, Hiroshima University Foundation, the Mochida Memorial Foundation and the Ryoich Naito Foundation for Medical Research. K.T.-S. is a Research Fellow of the Japan Society for the Promotion of Science.
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